Literature DB >> 10545709

Comparative genomic hybridization analysis of hepatoblastomas: additional evidence for a genetic link with Wilms tumor and rhabdomyosarcoma.

M Steenman1, G Tomlinson, A Westerveld, M Mannens.   

Abstract

We applied the technique of comparative genomic hybridization (CGH) to a series of 16 hepatoblastomas. Our goals were (1) to identify all quantitative chromosome abnormalities that appear in this type of tumor and (2) to compare the results with data from similar studies on other tumors associated with the Beckwith-Wiedemann syndrome (BWS). We found that the most commonly detected (> 30%) chromosome abnormalities were gains of chromosomes 1, 2, 7, 8, and 17. Losses of chromosomes were found in only a few cases. On comparing our results with those from studies on the BWS-associated tumors, Wilms tumor and rhabdomyosarcoma, it became clear that three chromosome regions, namely, 7q, 8q, and 17q, were the ones most commonly involved in all three types of tumors. These regions, therefore, may harbor genes that play a role in the etiology of BWS-associated tumors in general.

Entities:  

Mesh:

Year:  1999        PMID: 10545709     DOI: 10.1159/000015371

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  3 in total

1.  Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.

Authors:  R G Weber; T Pietsch; D von Schweinitz; P Lichter
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas.

Authors:  S G Gray; S Kytölä; T Matsunaga; C Larsson; T J Ekström
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

3.  Frequent increase of DNA copy number in the 2q24 chromosomal region and its association with a poor clinical outcome in hepatoblastoma: cytogenetic and comparative genomic hybridization analysis.

Authors:  K Kumon; H Kobayashi; T Namiki; Y Tsunematsu; J Miyauchi; A Kikuta; Y Horikoshi; Y Komada; Y Hatae; H Eguchi; Y Kaneko
Journal:  Jpn J Cancer Res       Date:  2001-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.